Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors
Clinical trial NCT06285071 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06285071
- Sponsor
- Novo Nordisk A/S
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2024-08-08
- Primary completion
- 2030-04-30
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.